Project Grant G11TW013062

Award Date 5/19/25
Completion Date 2/29/28
Dollars Obligated $101K
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Uganda
Similar Awards
This Project Grant award, titled "EXPANDED STRENGTHENING OF MAKERERE UNIVERSITY'S RESEARCH ADMINISTRATION CAPACITY PROGRAM (E-SMAC)", is provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $101,290 grant aims to strengthen NIH grants administration at Makerere University College of Health Sciences in Uganda by providing advanced training and mentoring to senior research...
This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $749,200 to the Regents of the University of Minnesota to establish the Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium in Uganda. The program aims to expand research expertise in neuro-infectious diseases by training at least 12 physician-scientists over 5 years. Key activities include providing 2-3 year mentored research...
This Project Grant award from the Fogarty International Center (CFDA 93.989), a program of the National Institutes of Health, provides $174,753 to Yale University to establish a registry of patients with HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda. The goal is to create a research and training platform to advance the understanding of the interplay between HIV and RMDs, which has been a significant but understudied challenge in sub-Saharan Africa. The project will leverage...
This $109,704 Project Grant award from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) supports an implementation research project focused on integrating tuberculosis (TB) treatment into community pharmacies in Uganda to improve outcomes for people living with HIV/TB co-infection. The grantee, The Infectious Diseases Institute (IDI) in Kampala, Uganda, will: 1) explore barriers and facilitators to this intervention, 2)...
This $1,103,953 Project Grant award, funded by the National Institute on Aging (NIA) under CFDA 93.866 (Aging Research), supports a study to measure the epidemiology of cognitive impairment and dementia among people living with HIV in rural southwestern Uganda. The study will be conducted by Massachusetts General Hospital in collaboration with the Mbarara University of Science and Technology (MUST) and the Kabwohe Clinical Research Center (KCRC) in Uganda. Key products and services to be...
This $108,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to strengthen the pre-award grants management capacity at Kenyatta National Hospital (KNH) in Kenya. The key objectives are to: 1) train two senior KNH research administrators on pre-award grant management processes at the University of Washington and NIH; 2) develop institutional pre-award processes compliant...
This Project Grant award from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $174,687 to The Infectious Diseases Institute LIMITED (IDI) in Kampala, Uganda to investigate the long-term neurological outcomes of HIV-associated cryptococcal meningitis. The key objectives are to: 1) Determine the prevalence of sustained neurocognitive impairment at 1 year among survivors of cryptococcal meningitis, and 2)...
This federal Project Grant award of $685,637 from the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research aims to enhance research on inflammation and cognitive health among adolescents and young adults (AYA) living with perinatally acquired HIV (PHIV) and adversity in Uganda. The award supports a comprehensive study to investigate the relationship between immune dysfunction, inflammation, and...
This Project Grant award of $646,561 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a study to evaluate the impact of a peer-navigation strategy on improving tuberculosis (TB) and HIV treatment adherence and outcomes among individuals in Uganda. The study aims to adapt and implement a multi-component peer-led TB education and adherence counseling intervention, and conduct a cluster-randomized trial to assess...
This federal Project Grant award of $547,321 from the National Institute of Mental Health (NIMH), under CFDA 93.242 Mental Health Research Grants program, aims to develop and pilot test an intervention called "Kayungirizi" to promote pre-exposure prophylaxis (PrEP) initiation and persistence among male clients of female sex workers (FSW) in Kampala, Uganda. The key components of the intervention involve: 1) Secondary distribution of HIV self-testing (HIVST) kits by FSW to their male...

This Project Grant award from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $100,987 to strengthen the research compliance and integrity (RCI) office capacity at the Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration in Uganda. The overarching goal is to equip the RCI team with knowledge, skills, and established policies and procedures to rigorously review and monitor the conduct of HIV clinical trials. Key activities include:

  • Advanced training for the RCI lead staff at Johns Hopkins University, the HHS Office of Research Integrity, and the Africa Institute for Regulatory Affairs
  • Training and mentorship for the RCI co-lead, regulatory affairs coordinators, and other compliance staff at MU-JHU and Baylor Foundation Uganda
  • Establishment of a hybrid compliance and integrity support hub at MU-JHU to provide low-cost training and assistance to other Ugandan research staff involved in regulatory and compliance activities

The award period runs from May 2025 to February 2028, with the aim of creating an institutional compliance and integrity leader, strengthening compliance teams, and improving clinical trial compliance practices at the institutional level in Uganda.

Generated 6/17/25, 4:53 AM